Investing Trends

Examining the Revenue Side of a Potential Investment

This week, we’ll touch on the potential revenue side, as well as how all of this shakes out...

Why Bad Things Happen Under the 200-Day Average

To describe this wild week as anything but the epitome of craziness would be the height of understatement.

Is the Bull Run in Biotech over?

In a bull market that’s six-plus years old, bull runs in hot sectors become increasingly scarce commodities.

[happy investor up arrows]

Momentum Fund Speeds into First Place

Just because the U.S. market isn’t offering easy money doesn’t mean it isn’t possible for individual investors to...

How High-Yield Assets are Performing in 2015

From Greece to China to the corner of Wall St. and Broad St., things were indeed wild.

How ‘Smart Beta’ Funds Outperform the Market

Some things just get better with age. Other predictions prove prescient, confirmed with the benefit of 20:20 hindsight....

How ‘Exponential’ Investing Can Generate Massive Returns

Technology is back. With the U.S. Nasdaq hitting the 5,000 level on March 10 for the first time...

This Simple Strategy Tracks the ‘Big Catalysts’

It may sound pretty simple, but many people tend to overlook the calendar as a source of catalysts...

Falling Oil’s Ripple Effects

If you assumed that oil prices were the only culprit behind the deflation we are seeing, then you’d...

What the Apple Watch Means for Apple

Apple has a history of shifting the landscape. Its iPod not only shook up, but shattered, the way...